Skip to main content

Celecoxib (International)

In the US, Celecoxib (celecoxib systemic) is a member of the drug class cox-2 inhibitors and is used to treat Ankylosing Spondylitis, Chronic Pain, Familial Adenomatous Polyposis, Fibromatosis, Headache, Juvenile Rheumatoid Arthritis, Migraine, Osteoarthritis, Pain, Period Pain, Rheumatoid Arthritis and Spondyloarthritis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX33,M01AH01

CAS registry number (Chemical Abstracts Service)

0169590-42-5

Chemical Formula

C17-H14-F3-N3-O2-S

Molecular Weight

381

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Adjunct to antineoplastic treatment of adenomatous colorectal polyps

Cyclo-oxygenase 2 (COX-2) inhibitor

Chemical Name

4-(5-(4-Metylphenyl)-3-(trifluorometyl)-1H-pyrazol-1-yl)benzenesulfonamide (IUPAC)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.